Medicine shortage communication (MSC): Topamax, Topimax, Epitomax, Topamac supply shortage
Withdrawn application: DuoResp Spiromax, 27/04/2026
Withdrawn application: BiResp Spiromax, 27/04/2026
Guideline on data requirements for authorisation of immunological veterinary medicinal products in exceptional circumstances - Scientific guideline
Updates to industry contact management for authorisation products (IRIS), Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 June 2026, 11:00 (CEST) to 11 June 2026, 12:15 (CEST)
HMA-EMA Network Data Steering Group: membership list
Step-by-step guide : Support with workload management in the authority workspace - CTIS Training Programme - Module 04
FAQs: Support with workload management by workspace - CTIS Training Programme - Module 04
Clinical Trial Information System (CTIS) - Sponsor handbook
EFIM Annual Report 2025 Published
We are pleased to announce that the EFIM Annual Report 2025 is now available.
The report provides an overview of EFIM’s activities, achievements, and key developments throughout the year.
We invite our national socieities members, partners, and the wider community to explore the report and learn more about EFIM's initiatives and projects.
Read the full Annual Report here: Annual Report 2025